Also, CXCR2+ MDSCs are the primary subpopulation mediating immune escape in the TME of pancreatic and hepatocellular carcinoma, which can be reversed by CXCR2 antagonists (Steele et al., 2016; Wang et al., 2022). The gene discussed is CXCR2; the disease is hepatocellular carcinoma.